Home > Back to Publisher > Report Information

The World Market for Medicaments Containing Hormones, Their Derivatives, and Other Steriods Used as Hormones Excluding Antibiotics and Their Derivatives: A 2004 Global Trade Perspective

Icon Group International, Inc.
June 3, 2003
162 Pages - SKU: ICN918135

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Global

The World Market for Medicaments Containing Hormones, Their Derivatives, and Other Steriods Used as Hormones Excluding Antibiotics and Their Derivatives: A 2004 Global Trade Perspective

This report was created for strategic planners, international executives and import/export managers who are concerned with the market for medicaments containing hormones, their derivatives, and other steriods used as hormones excluding antibiotics and their derivatives. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for medicaments containing hormones, their derivatives, and other steriods used as hormones excluding antibiotics and their derivatives for those countries serving the world market via exports or supplying from various countries via imports. I do so for the current year based on a variety of key historical indicators and econometric models.

Excerpt: On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying medicaments containing hormones, their derivatives, and other steriods used as hormones excluding antibiotics and their derivatives? What is the dollar value of these imports? How much do the imports of medicaments containing hormones, their derivatives, and other steriods used as hormones excluding antibiotics and their derivatives vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of medicaments containing hormones, their derivatives, and other steriods used as hormones excluding antibiotics and their derivatives? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers?

In what follows, Chapter 2 begins by summarizing the regional markets for imported and exported medicaments containing hormones, their derivatives, and other steriods used as hormones excluding antibiotics and their derivatives. The total level of imports and exports on a worldwide basis, and those for each region, is based on a model which aggregates across country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on both demand- and supply-side dynamics, market shares by country of origin are then calculated across each country market destination. These shares lead to a volume of import and export values for each country and are aggregated to regional and world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value of each market and the shares that countries are likely to receive this year. From these figures, rankings are calculated to allow managers to prioritize markets. In this way, all the figures provided in this report are forecasts that can be combined with internal information for strategic planning purposes.

After the worldwide summary in Chapter 2 of both imports and exports, Chapter 3 details the exports of medicaments containing hormones, their derivatives, and other steriods used as hormones excluding antibiotics and their derivatives, for each individual country. Chapter 4 does the same, but for imports of medicaments containing hormones, their derivatives, and other steriods used as hormones excluding antibiotics and their derivatives for all countries in the world. In all cases, the total dollar volume and percentage share values by major trading partner are provided. Combined, Chapters 3 and 4 present the complete picture for imports and exports of medicaments containing hormones, their derivatives, and other steriods used as hormones excluding antibiotics and their derivatives to and from all major countries in the world. Of the countries considered, if a country is not reported here it is therefore estimated to have only a negligible level of trade in medicaments containing hormones, their derivatives, and other steriods used as hormones excluding antibiotics and their derivatives (i.e. their market shares are close or equal to zero percent). "Medicaments Containing Hormones, Their Derivatives, and Other Steriods Used as Hormones Excluding Antibiotics and Their Derivatives" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defined "medicaments containing hormones, their derivatives, and other steriods used as hormones excluding antibiotics and their derivatives" is 5422.

1   METHODOLOGY
1.1   Our Approach
2   THE WORLD MARKET
2.1   Exports
2.1.1   The World Market: Exports in 2004
2.2   Imports
2.2.1   The World Market: Imports in 2004
3   EXPORTS
3.1   Africa: Export Supplies in 2004
3.1.1   Executive Summary
3.1.2   Burkina Faso
3.1.3   Egypt
3.1.4   Kenya
3.1.5   Namibia
3.1.6   South Africa
3.1.7   Uganda
3.1.8   Zimbabwe
3.2   Asia: Export Supplies in 2004
3.2.1   Executive Summary
3.2.2   Bangladesh
3.2.3   Brunei
3.2.4   China
3.2.5   Hong Kong
3.2.6   India
3.2.7   Indonesia
3.2.8   Japan
3.2.9   Malaysia
3.2.10   North Korea
3.2.11   Philippines
3.2.12   Singapore
3.2.13   South Korea
3.2.14   Taiwan
3.2.15   Thailand
3.3   Europe: Export Supplies in 2004
3.3.1   Executive Summary
3.3.2   Austria
3.3.3   Belarus
3.3.4   Belgium
3.3.5   Bulgaria
3.3.6   Croatia
3.3.7   Cyprus
3.3.8   Czech Republic
3.3.9   Denmark
3.3.10   Estonia
3.3.11   Finland
3.3.12   France
3.3.13   Georgia
3.3.14   Germany
3.3.15   Greece
3.3.16   Hungary
3.3.17   Iceland
3.3.18   Ireland
3.3.19   Italy
3.3.20   Latvia
3.3.21   Lithuania
3.3.22   Macedonia
3.3.23   Netherlands
3.3.24   Norway
3.3.25   Poland
3.3.26   Portugal
3.3.27   Romania
3.3.28   Russia
3.3.29   Serbia & Montenegro
3.3.30   Slovakia
3.3.31   Slovenia
3.3.32   Spain
3.3.33   Sweden
3.3.34   Switzerland
3.3.35   Ukraine
3.3.36   United Kingdom
3.4   Latin America: Export Supplies in 2004
3.4.1   Executive Summary
3.4.2   Argentina
3.4.3   Brazil
3.4.4   Chile
3.4.5   Colombia
3.4.6   Costa Rica
3.4.7   Ecuador
3.4.8   El Salvador
3.4.9   Guatemala
3.4.10   Honduras
3.4.11   Mexico
3.4.12   Panama
3.4.13   Peru
3.4.14   Uruguay
3.4.15   Venezuela
3.5   N. America & Caribbean: Export Supplies in 2004
3.5.1   Executive Summary
3.5.2   Aruba
3.5.3   Bermuda
3.5.4   Canada
3.5.5   Cuba
3.5.6   Dominican Republic
3.5.7   United States
3.6   Oceana: Export Supplies in 2004
3.6.1   Executive Summary
3.6.2   Australia
3.6.3   New Zealand
3.7   The Middle East: Export Supplies in 2004
3.7.1   Executive Summary
3.7.2   Iran
3.7.3   Israel
3.7.4   Jordan
3.7.5   Pakistan
3.7.6   Saudi Arabia
3.7.7   Turkey
3.7.8   United Arab Emirates
3.7.9   Uzbekistan
4   IMPORTS
4.1   Africa: Imports in 2004
4.1.1   Executive Summary
4.1.2   Algeria
4.1.3   Burundi
4.1.4   Ethiopia
4.1.5   Ghana
4.1.6   Ivory coast
4.1.7   Kenya
4.1.8   Mauritius
4.1.9   Morocco
4.1.10   Nigeria
4.1.11   Senegal
4.1.12   South Africa
4.1.13   Tunisia
4.1.14   Uganda
4.2   Asia: Imports in 2004
4.2.1   Executive Summary
4.2.2   China
4.2.3   Hong Kong
4.2.4   Indonesia
4.2.5   Japan
4.2.6   Macau
4.2.7   Malaysia
4.2.8   Papua New Guinea
4.2.9   Philippines
4.2.10   Singapore
4.2.11   South Korea
4.2.12   Thailand
4.3   Europe: Imports in 2004
4.3.1   Executive Summary
4.3.2   Albania
4.3.3   Austria
4.3.4   Belarus
4.3.5   Belgium
4.3.6   Bulgaria
4.3.7   Croatia
4.3.8   Cyprus
4.3.9   Czech Republic
4.3.10   Denmark
4.3.11   Estonia
4.3.12   Finland
4.3.13   France
4.3.14   Georgia
4.3.15   Germany
4.3.16   Hungary
4.3.17   Iceland
4.3.18   Ireland
4.3.19   Italy
4.3.20   Kazakhstan
4.3.21   Latvia
4.3.22   Lithuania
4.3.23   Malta
4.3.24   Moldova
4.3.25   Netherlands
4.3.26   Norway
4.3.27   Poland
4.3.28   Portugal
4.3.29   Romania
4.3.30   Russia
4.3.31   Slovenia
4.3.32   Spain
4.3.33   Sweden
4.3.34   Switzerland
4.3.35   United Kingdom
4.4   Latin America: Imports in 2004
4.4.1   Executive Summary
4.4.2   Argentina
4.4.3   Bolivia
4.4.4   Brazil
4.4.5   Chile
4.4.6   Colombia
4.4.7   Costa Rica
4.4.8   Ecuador
4.4.9   El Salvador
4.4.10   Guatemala
4.4.11   Honduras
4.4.12   Mexico
4.4.13   Nicaragua
4.4.14   Panama
4.4.15   Paraguay
4.4.16   Peru
4.4.17   Suriname
4.4.18   Uruguay
4.4.19   Venezuela
4.5   N. America & Caribbean: Imports in 2004
4.5.1   Executive Summary
4.5.2   Barbados
4.5.3   Canada
4.5.4   Jamaica
4.5.5   Trinidad and Tobago
4.5.6   United States
4.6   Oceana: Imports in 2004
4.6.1   Executive Summary
4.6.2   Australia
4.6.3   New Zealand
4.7   The Middle East: Imports in 2004
4.7.1   Executive Summary
4.7.2   Azerbaijan
4.7.3   Bahrain
4.7.4   Iran
4.7.5   Israel
4.7.6   Jordan
4.7.7   Pakistan
4.7.8   Turkey
4.7.9   Turkmenistan
5   DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS
5.1   Disclaimers & Safe Harbor
5.2   ICON Group Ltd. User Agreement Provisions

More Global Endocrinology/Metabolics Reports

2012 Global Endocrine Function Testing Market Outlook: Growth Opportunities and Strategies by Venture Planning Group
During the next decade, the endocrine function testing market will undergo significant transformation. These changes will be caused by convergence of new and more ...

Testosterone Replacement Therapy (TRT) by Global Industry Analysts
This report analyzes the worldwide markets for Testosterone Replacement Therapy (TRT) in US$ Million. The global and the US markets are further analyzed by the ...

Hormone Replacement Therapy (HRT) by Global Industry Analysts
This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, ...

Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 - Future Therapies for Birth Control and Reproductive Health by Spectra Intelligence
The current market for hormonal contraceptives and infertility drugs is estimated at US$9.4bn, and is forecast to increase by 7% in annual revenues to US$10bn ...

Testosterone Replacement Therapy (TRT) by Global Industry Analysts
This report analyzes the worldwide markets for Testosterone Replacement Therapy (TRT) in US$ Million. The global and the US markets are further analyzed by the ...

See all reports like this >>

The World Market for Medicaments Containing Hormones, Their Derivatives, and Other Steriods Used as Hormones Excluding Antibiotics and Their Derivatives: A 2004 Global Trade Perspective

Share this report

Other tasks

Research Assistance

Related Markets

Endocrinology/Metabolics Reports

Free Alert Me service